LabMD statement in response to FTC complaint
The following statement attributed to LabMD was sent to PHIprivacy.net:
LabMD Responds to Federal Trade Commission’s Witch Hunt
FTC action a clear example of federal government overreach
WASHINGTON – Today, the Federal Trade Commission (FTC) filed a complaint against LabMD claiming a violation of the Federal Trade Commission Act.
“The Federal Trade Commission’s enforcement action against LabMD based, in part, on the alleged actions of Internet trolls, is yet another example of the FTC’s pattern of abusing its authority to engage in an ongoing witch hunt against private businesses. The allegations in the FTC’s complaint are just that: allegations. LabMD looks forward to vigorously fighting against the FTC’s overreach by seeking recourse through the available legal processes.”
The FTC has repeatedly overstepped its statutory authority under Section 5 of the Federal Trade Commission Act and the FTC does not have the authority to bring this enforcement action.
LabMD is a cancer detection facility that specializes in analysis and diagnosis of blood, urine, and tissue specimens for cancers, micro-organisms and tumor markers.